British Journal of Pharmacology

30/08/2025

⭐ Editor’s choice: An interesting insight into how our blood cells behave during inflammation shows platelets can move toward inflammation signals without causing clots, when triggered by P2Y14 and P2Y1 receptor activation.

🩸 Read the paper for free in the British Journal of Pharmacology: https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.70024

Congratulations to everyone who contributed to this article, which has been awarded the British Journal of Pharmacology 'Editor's Choice' award by Editor in Chief, Prof. Péter Ferdinandy, MD, PhD, MBA.

Authors:
Md. Monir Hossain
Dingxin Pan
Kate L. Arkless
Khondaker Miraz Rahman
Clive page
Kalwant Authi
Simon Pitchford

29/08/2025

⭐ Editor’s choice: This research looks into a natural compound in the body, ARA-S, which could help fix faulty heart channels linked to a condition called long QT syndrome (LQTS), offering hope for safer, targeted treatments.

🫀 Read the paper for free in the British Journal of Pharmacology: https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.70008

Congratulations to everyone who contributed to this article, which has been awarded the British Journal of Pharmacology 'Editor's Choice' award by Editor in Chief, Prof. Péter Ferdinandy, MD, PhD, MBA.

Authors:
Irene Hiniesto Iñigo
Akshay Sridhar
Julien Louradour
Alicia De la Cruz
Siri Lundholm
Amaia Jauregi-Miguel
Federica Giannetti
Luca Sala
Katja E. Odening
H. Peter Larsson
Nina Ottosson
Sara Liin

27/08/2025

⭐ Editor’s choice: Most of our body’s GCPRs are still unexplored, but more research in this space could lead to powerful new treatments. This article dives into a subclass of understudied GPCRs, highlighting where we can still bridge gaps in knowledge.

🔍 Read the paper for free in the British Journal of Pharmacology: https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.16325

Congratulations to everyone who contributed to this article, which has been awarded the British Journal of Pharmacology 'Editor's Choice' award by Editor in Chief, Prof. Péter Ferdinandy, MD, PhD, MBA.

Authors:
Magdalena M. Scharf
Laura J. Humphrys
Sandra Berndt
Antonella Di Pizio
Juliane Lehmann
Liebscher Ines
Alessandro Nicoli
Masha Niv
Dr. Hannes Schihada
Gunnar Schulte

10/12/2024

And that’s day one of completed!
An incredible day of learning, sharing and networking - and all about our favourite topic 💊🔬🥼
If you’ve got conference FOMO, there’s still time - you can register for tomorrow and Wednesday in person at the Harrogate Convention Centre. https://ow.ly/PejF50UoB4L

09/12/2024

Good morning, Harrogate! 🌞
The BPS team has arrived in Harrogate, where we’re preparing for doors to open at tomorrow morning. We can’t wait to see you there!

03/12/2024

⬆️ Submit your papers to the British Journal of Pharmacology: https://bpspubs.onlinelibrary.wiley.com/hub/journal/14765381/publish-with-british-journal-of-pharmacology.html
⚡ We're a world-leading journal that is community-owned and has a quick, high-quality peer review process. Check out our call for papers: https://bpspubs.onlinelibrary.wiley.com/hub/journal/14765381/call-for-papers.html

01/11/2024

Submit your papers to BJP!

⬆️ World leading journal
👥 Community owned
⚡ Fast high-quality peer review
🔬 Transparency & scientific rigour
👐 Option to publish

Find out more: https://bpspubs.onlinelibrary.wiley.com/hub/journal/14765381/publish-with-british-journal-of-pharmacology.html
Call for papers: https://bpspubs.onlinelibrary.wiley.com/hub/journal/14765381/call-for-papers.html

31/10/2024

22/10/2024

IUPHAR Review 39 gives a comprehensive overview of the family, including their structural and functional features, highlighting the moldability of their energy landscapes and actions. It includes suggested best practices for unambiguous viroporin identification and characterisation. It also looks at viroporin targeting drugs.

Read now: https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bph.17317

21/10/2024

LIMS1 - A new target to fight against kidney fibrosis? https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.16358

Fibrosis is a key factor in the progression of hypertension and chronic kidney disease (CKD). Ni et al's study suggests that LIMS1 plays a central role in the fibrotic process and represents a promising therapeutic target for CKD.

01/10/2024

⬆️ Submit your papers to the British Journal of Pharmacology: https://ow.ly/Jp9z50Q26P3
⚡ We're a world-leading journal that is community-owned and has a quick, high-quality peer review process. Check out our call for papers: https://ow.ly/ZLnw50Q26P1